- Exchange: Natl India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Company Profile for Lupin Ltd (LPC)
Lupin Limited manufactures bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.
Contact Information
Lupin Ltd
159 CST Road
Kalina
Santacruz E Mumbai, 400 098
India
Key Executives for Lupin Ltd (LPC)
| Desh Bandhu GuptaChairman/Founder | Kamal K SharmaVice Chairman |
| Kamal K SharmaVice Chairman | Vinita GuptaChief Executive Officer |
| Nilesh D GuptaManaging Director | Ramesh SwaminathanPresident:Finance & Planning |
| Vinod DhawanPresident:Aamla & Business Dev | Shakti P ChakrabortyPresident:Formulations & CIS |
| Naresh Kumar GuptaPresident:API & Global TB | Rajender KambojPresident:Drug Discovery & Dev |
| Divakar KazaPresident:Human Resources | Alok Kumar GhoshPresident:Technical Operations |
| Cyrus KarkariaPresident:Biotechnology | Sunil MakhariaExec VP:Finance |
| Raghuvansh Singh RaghavExec VP:Mktg & Sales | Dhananjay BakhleExec VP:Medical Research |
| Debabrata ChakravortyExec VP:Supply Planning | Sofia MumtazExec VP:Ipmg |
| Rajendra ChunodkarExec VP:Technical | R V SatamSecretary/Compliance Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page